Christina Tatsi, Georgia Pitsava, Fabio R Faucz, Meg Keil, Constantine A Stratakis
{"title":"卡尼复合体生长激素过剩的范围以及基因型与表型的相关性。","authors":"Christina Tatsi, Georgia Pitsava, Fabio R Faucz, Meg Keil, Constantine A Stratakis","doi":"10.1210/clinem/dgae253","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Carney complex (CNC) is a familial neoplasia syndrome associated with GH excess (GHE).</p><p><strong>Objective: </strong>To describe the frequency of GHE in a large cohort of patients with CNC and to identify genotype-phenotype correlations.</p><p><strong>Methods: </strong>Patients with CNC with at least 1 biochemical evaluation of GH secretion at our center from 1995 to 2021 (n = 140) were included in the study. Diagnosis of GHE was based on levels of IGF-1, GH suppression during oral glucose tolerance test, GH stimulation after thyrotropin administration and overnight GH secretion.</p><p><strong>Results: </strong>Fifty patients (35.7%) had GHE, and 28 subjects (20%) had symptomatic acromegaly, with median age at diagnosis of 25.3 and 26.1 years, respectively. Most of the patients (99.3%) had a PRKAR1A gene defect. There was a higher risk of GHE in patients harboring a variant that led to no expression of the affected allele [hazard risk (HR): 3.06, 95% confidence interval (CI): 1.2-7.8] and for patients harboring the hotspot variant c.491_492delTG (HR: 2.10, 95% CI: 1.1-4.1). Almost half of patients with CNC had an abnormal finding on pituitary imaging. CNC patients with abnormal pituitary imaging had a higher risk of GHE (HR: 2.94, 95% CI: 1.5-5.8), especially when single or multiple adenoma-like lesions were identified. Management of patients with symptomatic acromegaly involved surgical and medical approaches.</p><p><strong>Conclusion: </strong>Dysregulation of GH secretion is a common finding in CNC. Knowing the clinical spectrum of this disorder and its association with genetic and imaging characteristics of the patient make more likely its prompt diagnosis and better management.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"e694-e702"},"PeriodicalIF":5.0000,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11834726/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Spectrum of GH Excess in Carney Complex and Genotype-phenotype Correlations.\",\"authors\":\"Christina Tatsi, Georgia Pitsava, Fabio R Faucz, Meg Keil, Constantine A Stratakis\",\"doi\":\"10.1210/clinem/dgae253\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Context: </strong>Carney complex (CNC) is a familial neoplasia syndrome associated with GH excess (GHE).</p><p><strong>Objective: </strong>To describe the frequency of GHE in a large cohort of patients with CNC and to identify genotype-phenotype correlations.</p><p><strong>Methods: </strong>Patients with CNC with at least 1 biochemical evaluation of GH secretion at our center from 1995 to 2021 (n = 140) were included in the study. Diagnosis of GHE was based on levels of IGF-1, GH suppression during oral glucose tolerance test, GH stimulation after thyrotropin administration and overnight GH secretion.</p><p><strong>Results: </strong>Fifty patients (35.7%) had GHE, and 28 subjects (20%) had symptomatic acromegaly, with median age at diagnosis of 25.3 and 26.1 years, respectively. Most of the patients (99.3%) had a PRKAR1A gene defect. There was a higher risk of GHE in patients harboring a variant that led to no expression of the affected allele [hazard risk (HR): 3.06, 95% confidence interval (CI): 1.2-7.8] and for patients harboring the hotspot variant c.491_492delTG (HR: 2.10, 95% CI: 1.1-4.1). Almost half of patients with CNC had an abnormal finding on pituitary imaging. CNC patients with abnormal pituitary imaging had a higher risk of GHE (HR: 2.94, 95% CI: 1.5-5.8), especially when single or multiple adenoma-like lesions were identified. Management of patients with symptomatic acromegaly involved surgical and medical approaches.</p><p><strong>Conclusion: </strong>Dysregulation of GH secretion is a common finding in CNC. Knowing the clinical spectrum of this disorder and its association with genetic and imaging characteristics of the patient make more likely its prompt diagnosis and better management.</p>\",\"PeriodicalId\":50238,\"journal\":{\"name\":\"Journal of Clinical Endocrinology & Metabolism\",\"volume\":\" \",\"pages\":\"e694-e702\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2025-02-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11834726/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Endocrinology & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1210/clinem/dgae253\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae253","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:卡尼综合征(CNC)是一种与生长激素(GH)过剩(GHE)相关的家族性肿瘤综合征:描述大量 CNC 患者中 GHE 的发生频率,并确定基因型与表型之间的相关性:研究纳入了 1995-2021 年间在本中心接受过至少一次 GH 分泌生化评估的 CNC 患者(n=140)。GHE的诊断依据是胰岛素样生长因子-1(IGF-1)水平、口服葡萄糖耐量试验(OGTT)中的GH抑制、促甲状腺激素(TRH)给药后的GH刺激以及过夜GH分泌:50名患者(35.7%)患有GHE,28名患者(20%)患有无症状肢端肥大症,确诊时的中位年龄分别为25.3岁和26.1岁。大多数患者(99.3%)存在PRKAR1A基因缺陷。携带导致受影响等位基因不表达的变异的患者[危险风险(HR):3.06,95% 置信区间(CI):1.2-7.8]和携带热点变异 c.491_492delTG 的患者(HR:2.10,95%CI:1.1-4.1)罹患 GHE 的风险较高。近半数 CNC 患者的垂体成像结果异常。垂体造影异常的 CNC 患者罹患 GHE 的风险更高(HR:2.94,95%CI:1.5-5.8),尤其是在发现单个或多个腺瘤样病变时。对有症状的肢端肥大症患者的治疗包括手术和药物治疗:结论:GH分泌失调是CNC的常见症状。这种疾病的临床表现及其与患者遗传和影像学特征的关联使得及时诊断和治疗更为成功。
The Spectrum of GH Excess in Carney Complex and Genotype-phenotype Correlations.
Context: Carney complex (CNC) is a familial neoplasia syndrome associated with GH excess (GHE).
Objective: To describe the frequency of GHE in a large cohort of patients with CNC and to identify genotype-phenotype correlations.
Methods: Patients with CNC with at least 1 biochemical evaluation of GH secretion at our center from 1995 to 2021 (n = 140) were included in the study. Diagnosis of GHE was based on levels of IGF-1, GH suppression during oral glucose tolerance test, GH stimulation after thyrotropin administration and overnight GH secretion.
Results: Fifty patients (35.7%) had GHE, and 28 subjects (20%) had symptomatic acromegaly, with median age at diagnosis of 25.3 and 26.1 years, respectively. Most of the patients (99.3%) had a PRKAR1A gene defect. There was a higher risk of GHE in patients harboring a variant that led to no expression of the affected allele [hazard risk (HR): 3.06, 95% confidence interval (CI): 1.2-7.8] and for patients harboring the hotspot variant c.491_492delTG (HR: 2.10, 95% CI: 1.1-4.1). Almost half of patients with CNC had an abnormal finding on pituitary imaging. CNC patients with abnormal pituitary imaging had a higher risk of GHE (HR: 2.94, 95% CI: 1.5-5.8), especially when single or multiple adenoma-like lesions were identified. Management of patients with symptomatic acromegaly involved surgical and medical approaches.
Conclusion: Dysregulation of GH secretion is a common finding in CNC. Knowing the clinical spectrum of this disorder and its association with genetic and imaging characteristics of the patient make more likely its prompt diagnosis and better management.
期刊介绍:
The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.